ILONA RABINOVICH: Open Payments
NPI 1114539368 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 47 payments from 9 companies in 2025. Trend: 2023 $968 · 2024 $1,418 · 2025 $862
Food & beverage: $811Education: $51
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 22 | $276 |
| Ardelyx, Inc. | 6 | $168 |
| ABBVIE INC. | 4 | $113 |
| Janssen Biotech, Inc. | 3 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $94 |
| Aimmune Therapeutics, Inc. | 2 | $60 |
| VIVUS LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 3 | $15 |
Products named: REZDIFFRA, IBSRELA, TREMFYA, XIFAXAN, ZENPEP, PANCREAZE, MAVYRET, ENTYVIO.
Industry payments across NY — which companies pay providers there.
